1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"DoD Breast Cancer, Breakthrough Award Levels 3" is currently closed and not accepting applications.
DoD Breast Cancer, Breakthrough Award Levels 3 is sponsored by Department of Defense, Defense Health Agency Contracting Activity - DHACA. This award supports advanced translational studies and research with high potential to lead to or make breakthroughs in breast cancer. The impact must move beyond a minor advancement and have the potential to lead to a fundamentally new strategy or approach.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - DoD Breast Cancer Breakthrough Award Level 3 DoD Breast Cancer Breakthrough Award Level 3 Agency: Defense Health Agency Contracting Activity - DHACA Assistance Listings: 12. 420 -- Military Medical Research and Development Last Updated: May 13, 2026 View version history on Grants. gov Summary: Supports promising research that has high potential to lead to or make breakthroughs in breast cancer.
All applications must address at least one of the fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) overarching challenges, unless adequate justification for exception is provided. Applications must address the challenge in a way that can lead to or make a breakthrough and have major impact.
The FY25 Breakthrough Award mechanism contains three different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level has a defined research scope. The current program announcement discusses the Breakthrough Award Level 3.
· For this funding mechanism, small-scale clinical trials are allowed but not required. Applications proposing projects with a clinical trial should be submitted under the Clinical Trial option. · The research team must include two or more breast cancer consumer advocates.
· This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage.
Be advised, applications may be withdrawn if both the initiating and partnering applications are not submitted by the full application deadline or if the initiating or partnering application is administratively withdrawn. Grantor contact information File name Description Last updated HT942525BCRPBTA3_GG2.
pdf FY25 BCRP BTA3 Program Announcement May 23, 2025 02:47 PM UTC Link to additional information Archived: October 10, 2025 Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Science technology and other research and development Your account requires additional identity verification.
According to the current listing, eligibility includes: Generally open to independent investigators at all academic levels. Most awards require inclusion of two or more consumer advocates on the research team. Confirm the full requirements in the official notice before applying.
The current listing shows up to $5,600,000 (Single PI) or $7,000,000 (Partnering PI Option) over 4 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was June 12, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
DoD Breast Cancer, Breakthrough Award Levels 3 is funded by Department of Defense, Defense Health Agency Contracting Activity - DHACA. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read articleDoW's 2026 SBIR Broad Agency Announcement now operates on a monthly pre-release / quarterly close cadence. The 42 topics closing June 24 are the first test of whether the new rhythm produces the steady-state deal flow defense innovators have been asking for since 2022.
Read article